Aster DM Quality Care Limited
Aster DM Quality Care Limited (ASTERDM): company summary
The company's business has seen revenue grow by 12.2% annually, but net profit has plummeted by 92.1% year-over-year.
Aster DM Quality Care Limited (ASTERDM) is a mid-cap Healthcare company valued at ₹58,733 crore operating in Hospital on the NSE and BSE.
- Recent price move
- Aster DM Quality Care Limited last traded at ₹675, modestly down 1.12% on the day.
- Recent developments
- On 2026-09-08, the company announced a capacity expansion, which may support future growth. On 2026-09-04, the founder's family increased its stake by purchasing shares worth ₹350 crore, signaling confidence. On 2026-08-29, the company acquired a 14.21% stake in STS Holdings, indicating strategic expansion. On 2026-08-20, the share price fell nearly 4%, likely due to market pressures.
- Financial performance
- The company's business has seen revenue grow by 12.2% annually, but net profit has plummeted by 92.1% year-over-year. In the latest quarter, revenue rose 21.6% compared to the same quarter a year earlier, but net profit dropped 68.9%, reflecting a significant deterioration in profitability.
- Valuation multiples
- The stock trades at 89.6 times earnings, a premium to the Healthcare median of 32.0, 15.89 times book value. It yields 0.4%.
- Things to watch
- The company's net profit margin has dropped 121.5 percentage points to 9.2%, indicating severe pressure on profitability. The stock is 21.5% below its 52-week high, showing a significant decline from recent peak levels. Promoter shares pledged account for 36.67% of their holding, raising concerns about liquidity and control.
- Where it stands
- The company is facing a sharp decline in net profit despite revenue growth, with the latest quarter showing a steep drop in profitability. The stock is trading 21.5% below its 52-week high, and promoter shares pledged represent a significant portion of their holding. The most significant movement is the sharp fall in net profit margin, which highlights ongoing challenges in maintaining profitability.
Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (6.2) and growth (6.0), but held back by valuation (0.0).
DocStoX score
Low confidenceAt a glance
Key highlights
- Profitable in all of the last 5 years
- Profit compounding 19% a year
- Revenue shrinking 12% a year
- 37% of promoter holding is pledged
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Hospital
Explore Aster DM Quality Care Limited’s valuation
Free deep-dive tools · no sign-up
Aster DM Quality Care Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Aster DM Quality Care Limited with peers
Related tools & concepts
Value Aster DM Quality Care Limited with the ratios and calculators DocStoX uses in its analysis.

